As researchers around the world continue to study the benefits of medicinal marijuana they conclude that cannabinoids within marijuana plants provide miraculous benefits for those with neurodegenerative diseases such as Parkinson’s, Alzheimer’s, Huntington’s disease, and multiple sclerosis.
In an attempt to understand marijuanas potential for alleviating neurodegenerative symptoms, a new study published in the International Journal of High-Risk Behavior and Addiction as well as PubMed.gov provided a very specific focus: “to highlight the role of the endocannabinoid system in neurodegenerative diseases.”
Providing analysis of the latest research available within the medical community on the topic, the researchers offered this exlpanation:
“endocannabinoids showed a neuromodulatory function, often of retrograde type… an important role in synaptic plasticity and in cognitive, motor, sensory and affective processes. In addition, in some acute or chronic pathologies of the central nervous system, such as neurodegenerative and neuroinflammatory diseases, endocannabinoids can perform a pro-homeostatic and neuroprotective function, through the activation of the CB1 and CB2 receptors.”
The results of this study were nothing less than inspirational for those that suffer from symptoms of a neurodegenerative disease:
“Scientific evidence shows that an hypofunction or a dysregulation of the endocannabinoid system may be responsible for some of the symptoms of diseases such as multiple sclerosis, amyotrophic lateral sclerosis, Huntington’s, Parkinson’s and Alzheimer’s diseases.”
This offers much hope for the millions who suffer from Parkinson’s, Alzheimer’s, Huntington’s Disease, Prion disease, Spinal muscular atrophy, and multiple sclerosis: that marijuana’s cannabinoids can modify their endocannabinoid system by the consumption of marijuanas cannabinoids.